dorsaVi Ltd (DVL) Fair Value & Analysis
Technology · AU · Market cap A$43.6M
Fair value as of: Jun 26, 2026
From 3 valuation models · updated 3 days ago
Fair value updated Jun 26, 2026 — revised from A$0.0100 to A$0.0254 (+154.1%) since Jun 24, 2026. Share price −19.0% over the past month.
Price vs Fair Value (12 months)
12‑month range A$0.0146 – A$0.0621 · the A$0.0330 price screens above the A$0.0254 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
dorsaVi Ltd (DVL) currently trades at A$0.0330, while our model-based Fair Value estimate is A$0.0254 — implying the stock looks roughly 23.0% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at A$999K. Revenue declined 19.9% year over year. The balance sheet holds a net cash position of A$2.1M. Fundamentals as of Jun 26, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
dorsaVi Ltd engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States. It operates through two segments: Clinical and Workplace. The company provides ViMove+, a clinical and sports solutions; ViSafe, a wearable sensor technology that analyzes how workforce moves and reviews and pinpoints unsafe work practices that leads to workplace injury; and myViSafe technology for organizations and on-site clinicians to identify and mitigate injury risk in the workplace and drive behavioral changes. It also offers ViPerform, a wearable and wireless movement sensor technology that offers objective data to assess risk of sport injury and guides athletic training and recovery programs; telehealth solutions; and professional suites. It serves clinic and sports, workplace, and research industries. dorsaVi Ltd was incorporated in 2008 and is based in Melbourne, Australia.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
dorsaVi Ltd reported revenue of A$1.1M in FY2025 versus A$1.9M in FY2021, a compound −11.8%/yr. Reported net income was −A$1.5M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Keyence Corporation KYCCF | $457.38 | $228.86 | -50% |
| Keysight Technologies, Inc KEYS | $373.34 | $93.51 | -75% |
| Garmin Ltd GRMN | $231.72 | $186.06 | -20% |
| Chroma ATE Inc 2360 | 2,190 TWD | 337.05 TWD | -85% |
| Teledyne Technologies Incorporated TDY | $601.35 | $358.39 | -40% |
| Hexagon AB HXGBF | $8.84 | $5.23 | -41% |
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is dorsaVi Ltd (DVL) undervalued?
What is the fair value of DVL?
What is the quality score of DVL?
What is the revenue of dorsaVi Ltd (DVL)?
What is the net profit margin of DVL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.